Acusphere, Inc.

Research and development agreement signed

Published in Managed Care Business Week, January 17th, 2006

Acusphere, Inc., (ACUS) has signed a master research and development agreement with a major pharmaceutical company to reformulate one of that company's water insoluble compounds utilizing Acusphere's Hydrophobic Drug Delivery Systems (HDDS) technology.

Acusphere also announced that it has been awarded an additional patent covering aspects of its HDDS technology, U.S. Patent No. 6,932,983, entitled "Porous Drug Matrices and Methods of Manufacture Thereof."

The partnership is a collaboration structured around a feasibility study to enhance the efficacy of a specific, existing hydrophobic anticancer agent. Success in this study could lead to the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Business Week

Source: Managed Care Business Week (2006-01-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry